Jon Congleton
CIK 1644975 · Chief Executive Officer · last filed 2026-07-15
Jon Congleton is a Chief Executive Officer who has filed 50 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing shows the insider sold $291.4K of MLYS on Jul 15, 2026. Across all open-market trades the lifetime net is −$15.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $16.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$16.53M
4
50
-$15.25M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLYS | Chief Executive Officer | 603,621 | $27.38 | $16.53M | -$15.36M | 23 | 2026-07-15 |
| IMUX | Director | — | $14.10 | — | $0 | 2 | 2026-07-07 |
| AVLN | Director | — | $34.56 | — | $0 | 1 | 2026-05-01 |
| ALPINE IMMUNE SCIENCES, INC. (NVLS) Delisted | President and CEO | 5,000 | — | — | $102.8K | 6 | 2016-09-14 |
Recent Filings
50 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-15 | MLYS | Sell (S) | −10,700 | -$291.4K | EDGAR |
| 2026-07-13 | MLYS | Notice (144) | −10,700 | -$291.4K | EDGAR |
| 2026-07-07 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2026-06-30 | MLYS | Notice (144) | −75,000 | -$1.96M | EDGAR |
| 2026-06-29 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2026-05-01 | AVLN | Grant (A) | — | $0 | EDGAR |
| 2026-04-15 | MLYS | Sell (S) | −15,730 | -$422.0K | EDGAR |
| 2026-04-13 | MLYS | Notice (144) | −15,730 | -$422.0K | EDGAR |
| 2026-04-02 | MLYS | Sell (S) | −75,000 | -$1.97M | EDGAR |
| 2026-03-31 | MLYS | Notice (144) | −75,000 | -$1.97M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.